ePharmacy Market Size was valued at USD 65.38 Billion in 2023. The Global ePharmacy industry is projected to grow from USD 67.19 Billion in 2024 to USD 110.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.10% during the forecast period (2024 - 2032).
Increasing online orders, rising investment for small companies and a rising number of counterfeit online pharmacies are the key market driver enhancing market growth.
In January 2022, Hyphens Pharma, a firm specializing in pharmaceuticals and consumer healthcare, officially introduced Singapore's inaugural digital pharmacy, which has received approval from the Health Sciences Authority. Hyphens Pharma operates in three distinct business sectors: specialized pharmaceuticals, proprietary brands, and medical hypermart and digital. It has successfully expanded its operations in key Southeast Asian nations, including as Singapore, Vietnam, Malaysia, Indonesia, and the Philippines. In addition, the group operates a marketing and distribution network that spans an additional 10 markets in the Asia-Pacific region. Through its digital initiative DocMed, the company has launched a new business called WellAway.
WellAway enables consumers to obtain e-prescriptions from certified doctors and have their prescribed medications delivered to their doorstep. According to a press statement, WellAway services are beneficial for people who are elderly, unable to move, practicing self-isolation, or just wish to reduce their interactions outside their home during the current pandemic. An HSA-registered e-pharmacy is required to provide traceable digital prescriptions directly from clinics and safeguard patient data by implementing cybersecurity measures. Competent pharmacists are responsible for managing pharmacy operations, which encompass the storage and distribution of authorized medicinal items.
In addition to these features, WellAway has also implemented specialized protocols for the proper handling of medication that is sensitive to temperature. Hyphens Pharma is currently engaged in a collaboration with Servier Singapore, a pharmaceutical business, in order to further the development of its innovative e-pharmacy service.
Patients no longer need to see the pharmacist thanks to the advent of ePharmacy. Additionally, after the pandemic, the e-pharmacy industry will have a huge growth due to consumers becoming more familiar with different e-pharmacy services and an increase in the use of online services because of their increasing penetration and uptake. With the growing usage of the Internet and e-commerce, there is a rising demand for mail-order medications. Numerous online drug stores, called ePharmacies, provide doorstep pickup and administration of prescription drugs and OTC items. However, a prescription from a doctor is necessary for ordering and receiving a prescription drug via an online channel. Online pharmacies emerged as one of the biggest benefactors of the pandemic-induced lockdown, even though medical stores were considered essential services since people opted to purchase their medications online to reduce the danger of disease transmission.
An increase in internet users, easier access to web-based and online services, and e-prescriptions within hospitals and other healthcare facilities all contribute to the growth of the e-pharmacy market. The key benefit of e-prescriptions is that they simplify getting medications online without any hassle by just uploading them to the e-pharmacy website. Therefore, posting prescriptions online has grown easier and quicker due to the growing use of e-prescriptions. The electronic prescribing technology known as "e-prescription" enables healthcare providers to eliminate paper by transmitting prescriptions in digital format instead of handwritten prescriptions. Doctors now favor electronic prescriptions so that patients can promptly get medication. E-prescription deployment is receiving more attention in nations like the UK. The primary drivers driving the market growth include an increase in tech-savvy consumers, better digitizing of medical care, and rising internet penetration around the globe.
Convenience-focused consumers who prefer to purchase online are also contributing to the surge. Overall growth is predicted to be fueled by the growing use of digital technology and e-commerce in the healthcare sector. India is one of the nation’s converting the need to halt COVID-19's spread into an opportunity to build more durable health systems. Government attention to developing and enhancing the whole healthcare system can contribute to market growth. The over-the-counter medicine market is anticipated to increase profitably during the anticipated period. The segmental expansion is being significantly fueled by major industry trends like the conversion from Rx to OTC by pharmaceutical makers, a rise in the tendency for patients to self-medicate in developing nations, an increase in the burden of pain, and a preference for internet pharmacies among consumers.
Efficiency of ePharmacy in providing affordable medical products and the growing prevalence of e-commerce is driving the global market growth
Large patient pools worldwide prefer door-to-door delivery of healthcare products as certain medicines are unavailable in retail pharmacies. In addition, ePharmacies reduce reliance on third parties for procuring medicines and health supplies for chronically ill patients and the elderly. Moreover, increasing penetration and formation of internet resources are projected to boost the market CAGR.
The proliferation of e-commerce has made it easier for ePharmacy to reach a broad customer base in both developed and developing countries worldwide. This generation of millennials relies heavily on sourcing cosmetics and over-the-counter medications online. Various startups are also popping up worldwide with the emergence of new information technologies and algorithms that provide better consumer experience and customer satisfaction. New technologies based on artificial intelligence are estimated to improve customer satisfaction in the market. All these factors are cumulatively expected to boost the growth of the ePharmacy Market revenue.
Figure 1: Indian Pharmaceutical Industry from 2021-2030 (in billion USD)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Conversely, selling prescription drugs through online channels is subject to strict regulations. Prescription drug sales by ePharmacy in North America and Europe are highly regulated, requiring companies to comply with various regulations that can affect market growth in these regions. Few countries have legalized the sale of prescription drugs on online sites. Unregulated prescription drug sales, which may lead to online pharmacies' ban, are estimated to limit global market revenue.
The market segments of ePharmacy, based on the drug type, includes prescription drugs, and over the counter (OTC) drugs. The over the counter (OTC) drugs segment held the majority share in 2022 for the ePharmacy market revenue. The increased desire for OTC medical products, including drugs, is blamed for this growth. The demand for over-the-counter (OTC) products in the ePharmacy industry is increasing as a result of consumers' growing awareness of common diseases and primary medications.
The ePharmacy market data has been bifurcated by operating platform into app and website. The app segment dominated the market in 2022. These are online pharmacies that function via a mobile software. Customers can download the app, explore and buy prescription drugs, healthcare items, and other related items using their mobile devices, and have those items delivered right to their door.
The ePharmacy market segmentation includes pharmacy and direct. The direct segment led the market in 2022 and is anticipated to be the faster-growing segment during the forecast period, 2024-2032. In this model, ePharmacies offer goods directly to customers instead of using middlemen. Customers can use the ePharmacy's website or mobile app to explore and purchase medications and healthcare items..
March 2021: Co-op Health, a digital prescription service that offers individuals to obtain medication via an app or the web for pickup at a nearby pharmacy or home delivery, was acquired by Phoenix UK.
Figure 2: EPharmacy Market by Business Models, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
News
Flipkart, which Walmart owns, wants to grow its epharmacy, Flipkart Health+, throughout India. The large e-commerce company is looking into cities outside of Tier-I to compete with its rivals. This process started with the epharmacy to transport medications and other items nationwide, including rural places. Currently, Flipkart Health+ offers 83,000 pharmaceuticals and healthcare items, shipping to about 20,000 pin codes nationwide. A library of materials and videos regarding general healthcare is also available on the portal.
By region, the study offers market insights into Asia-Pacific, Europe, North America, and Rest of the World. The North America EPharmacy market accounted for USD 30.18 billion in 2022 and is anticipated to exhibit a substantial CAGR growth during the study period, attributed to the Over-reliance of the general public on online delivery of consumables, including over-the-counter healthcare products such as vitamins, nutritional supplements, and cosmetics, is expected to have a positive impact on ePharmacy market trends.
Further, the key countries studied in the market report are: The U.S, Canada, UK, Italy, Spain, Germany, France, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: EPHARMACY MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's EPharmacy market accounts for the second-largest market share due to the lucrative price offering by major companies operating in the market. The extensive presence of biotech companies fuels the market's growth. Major European players are more focused on adopting AI-based analytical tools to enhance operational efficiency, which also plays an important role in market growth. Further, the Germany market of ePharmacy held the largest market share, and the United Kingdom market of ePharmacy was the fastest growing market in the European region
The Asia-Pacific market of ePharmacy, is anticipated to increase at the fastest CAGR from 2024 to 2032 due to the entry of key market players, growing healthcare IT expenditures, developing healthcare infrastructure, rising penetration of the internet and higher adoption of e-commerce websites. Further, the China market of ePharmacy held the largest market share, and the India Kingdom market of ePharmacy was the fastest growing market in the region
ePharmacy Key Market Players & Competitive Insights
Key market players are spending a large portion of money on research & development to increase their product lines, which will help the market of ePharmacy grow even more. Market players are also taking several strategic initiatives to increase their worldwide footprint, with key market developments such as mergers and acquisitions, contractual agreements, increased investments, new product launches, and collaboration with other organizations. Competitors in the ePharmacy industry must expand their business footprint to survive in an increasingly competitive and rising market environment.
One of the manufacturers primary business strategies in the global ePharmacy industry is to help clients and increase the market sector by increasing investment in R&D to enhance solutions and services. In recent years, the ePharmacy industry has provided transparency and reduced disruptions in the supply chain. The market of ePharmacy major players such as 3M, B. Braun Melsungen AG, Baxter International INC, Smith & Nephew Plc, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Integra Lifesciences Holdings Corporation, Mölnlycke Health Care AB, Avery Dennison Corporation, Hyphens Pharma International Limited and others are functioning on expanding the market demand by financing in research and development actions.
Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. For instance, In January 2022, Hyphens Pharma International Limited launched WellAway ePharmacy. WellAway provides customers easy access to pharmaceutical services and supports doctors with remote consultations.
Cardinal Health, Inc. is a pharmaceutical distributor, a global manufacturer and a distributor of medical and research products. Also, it is a provider of data solutions and performance for healthcare facilities. For instance, in January 2023, Cardinal Health announced its collaboration with Palantir Technologies Inc. to design a solution that will give health systems and hospitals dynamic purchase decision insights to improve their bottom line quickly.
Key Companies in the market of ePharmacy include
ePharmacy Industry Developments
September 2022: Amazon planned to sell prescription drugs online in Japan. She aims to work with small and medium-sized pharmacies to build a platform where patients can be instructed online on how to take their medication. Customers can have their medicines delivered to their homes without going to the pharmacy.
September 2022: Walmart Canada partnered with Canada Health Infoway. Infoway's PrescribeIT e-prescription service is currently available at 14 Walmart Canada pharmacies in Alberta, Ontario, New Brunswick, and Saskatchewan, with planned to expand to other locations by the year’s end.
January 2019: Zur Rose Group has completed the acquisition of the e-commerce business of medpex, Germany's third-largest online pharmacy. In this way, the Zur Rose Group significantly increased its market share in Germany.
February 2022: Medicure Inc. has launched a domestic consumer e-commerce pharmacy platform through its US subsidiary, Marley Drug Pharmacy. This will allow Americans to buy FDA-approved medicines at bargain prices on Marley Drugs' new e-commerce site, with home delivery to all 50 states..
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 65.38 billion |
| Market Size 2024 | USD 67.19 billion |
| Market Size 2032 | USD 110.2 billion |
| Compound Annual Growth Rate (CAGR) | 12.50% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018 & 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends |
| Segments Covered | Drug Type, Operating Platform, Business Models, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, UK, Italy, Germany, France, Spain, India, China, Japan, Australia, South Korea, and Brazil |
| Key Companies Profiled | 3M, B. Braun Melsungen AG, Baxter International INC, Smith & Nephew Plc, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Integra Lifesciences Holdings Corporation, Mölnlycke Health Care AB, Avery Dennison Corporation, and Hyphens Pharma International Limited |
| Key Market Opportunities | · Rising penetration of the internet |
| Key Market Dynamics | · The higher efficiency of online pharmacies in providing low-cost medical products |
Frequently Asked Questions (FAQ) :
The market size of global ePharmacy was valued at USD 65.38 Billion in 2023
The global market is projected to grow at a CAGR of 12.10% during the forecast period, 2024-2032.
North America had the leading share of the global market
The key players in the market are 3M, B. Braun Melsungen AG, Baxter International INC, Smith & Nephew Plc, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Integra Lifesciences Holdings Corporation, Mölnlycke Health Care AB, Avery Dennison Corporation, and Hyphens Pharma International Limited, and others.
The foam dressings ePharmacy category dominated the market in 2022.
The surgical and traumatic wounds operating platform had the largest global market share.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
